• SPX
  • $5,764.83
  • 0.91 %
  • $52.14
  • DJI
  • $42,103.32
  • 0.74 %
  • $308.71
  • N225
  • $38,474.90
  • 1.11 %
  • $421.23
  • FTSE
  • $8,178.05
  • -0.08 %
  • -$6.19
  • IXIC
  • $18,378.11
  • 1.09 %
  • $198.12

Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts?

By Yahoo! Finance   |   Jun 29, 2024 at 08:45 PM EST
Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts?

A list of top biotech penny stocks includes Inozyme Pharma, Inc. (NASDAQ:INZY) showing promise in rare disease therapeutics. Analysts rate it a Strong Buy with potential for significant growth.

Read More

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.